The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Margherita Strolin Benedetti

UCB Pharma SA

Belgium

[email]@ucb-group.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • UCB Pharma SA, Belgium. 2009
  • Non Clinical Development Department, UCB Pharma S.A., 21 rue de Neuilly, 92000 Nanterre, France. 2008
  • UCB Pharma, Non Clinical Development, Nanterre, France. 2001 - 2007
  • UCB S. A., Pharma Sector, Department of Global Product Safety and Metabolism, 21 rue de Neuilly, France. 2004
  • UCB Pharma, Nanterre, France. 2000

References

  1. Drug metabolism and pharmacokinetics. Benedetti, M.S., Whomsley, R., Poggesi, I., Cawello, W., Mathy, F.X., Delporte, M.L., Papeleu, P., Watelet, J.B. Drug Metab. Rev. (2009) [Pubmed]
  2. Stereoselective renal tubular secretion of levocetirizine and dextrocetirizine, the two enantiomers of the H1-antihistamine cetirizine. Strolin Benedetti, M., Whomsley, R., Mathy, F.X., Jacques, P., Espie, P., Canning, M. Fundam. Clin. Pharmacol (2008) [Pubmed]
  3. Factors affecting the relative importance of amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans. Strolin Benedetti, M., Tipton, K.F., Whomsley, R., Baltes, E. J. Neural. Transm (2007) [Pubmed]
  4. Drug metabolism in the paediatric population and in the elderly. Benedetti, M.S., Whomsley, R., Canning, M. Drug Discov. Today (2007) [Pubmed]
  5. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Strolin Benedetti, M., Whomsley, R., Baltes, E. Expert. Opin. Drug. Metab. Toxicol (2006) [Pubmed]
  6. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Strolin Benedetti, M., Whomsley, R., Baltes, E.L. Expert. Opin. Drug. Metab. Toxicol (2005) [Pubmed]
  7. Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog. Benedetti, M.S., Coupez, R., Whomsley, R., Nicolas, J.M., Collart, P., Baltes, E. Xenobiotica (2004) [Pubmed]
  8. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers. Strolin Benedetti, M., Whomsley, R., Nicolas, J.M., Young, C., Baltes, E. Eur. J. Clin. Pharmacol. (2003) [Pubmed]
  9. Biotransformation of xenobiotics by amine oxidases. Benedetti, M.S. Fundam. Clin. Pharmacol (2001) [Pubmed]
  10. Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. Benedetti, M.S., Plisnier, M., Kaise, J., Maier, L., Baltes, E., Arendt, C., McCracken, N. Eur. J. Clin. Pharmacol. (2001) [Pubmed]
  11. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Benedetti, M.S. Fundam. Clin. Pharmacol (2000) [Pubmed]
 
WikiGenes - Universities